What is the global market size of Cardiac Monitoring and Cardiac Rhythm Management Devices Market?

Global Cardiac Monitoring and Cardiac Rhythm Management Devices Market size was valued at USD 17.82 billion in 2021 and is poised to grow from USD 18.8 billion in 2022 to USD 31.1 billion by 2030, growing at a CAGR of 5.5% in the forecast period (2023-2030).

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis, By Cardiac Monitoring Devices Type (ECG Devices, Resting ECG Devices), By Cardiac Rhythm Management Devices Type (Defibrillators, Implantable Cardioverter Defibrillators), By Procedure (Invasive Procedures, Non-Invasive Procedures), By Application, By End User, By Region - Industry Forecast 2025-2032

Report ID: SQMIG35A2212 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 62 | Figures: 75

Cardiac Monitoring and Cardiac Rhythm Management Devices Market News

On 18 February 2021, RhythMedix, a company in remote cardiac monitoring based in New Jersey, U.S. introduced nextgeneration RhythmStar wearable with integrated 4G cellular connectivity. This innovative cardiac telemetry monitor is covertly worn for prolonged remote monitoring with no additional phone or communication gear required. RhythMedix's team of U.S.-based qualified technicians can quickly analyze an Electrocardiogram (ECG) and report any cardiac abnormalities, alerting doctors if an arrhythmia of concern is found. HeartTime on-demand telemetry mode, a cutting edge platform, is now offered with RhythmStar, that enables doctors to assess heart activity and speed care via a telemedicine consultation, reducing the need for an in-person office visit.

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cardiac Monitoring And Cardiac Rhythm Management Devices Market size was valued at USD 21.2 billion in 2022 and is poised to grow from USD 22.15 billion in 2023 to USD 31.51 billion by 2031, growing at a CAGR of 4.5% during the forecast period (2024-2031).

There are a lot of large and medium-sized players in the global market for cardiac monitoring and cardiac rhythm management devices, which is fairly fragmented. Major players are employing a variety of strategies, concluding strategic agreements and contracts, entering into mergers and acquisitions, and developing and introducing more efficient devices. 'Biotronik SE & Co. KG ', 'Medtronic ', 'Boston Scientific ', 'Abbott Laboratories ', 'GE Healthcare ', 'Philips Healthcare ', 'Nihon Kohden ', 'Schiller ', 'Edwards Lifesciences ', 'Spacelabs Healthcare ', 'OSI Systems ', 'Mindray Medical ', 'Fukuda Denshi ', 'Innomed Medical ', 'Biotronik ', 'Progetti Srl ', 'Zoll Medical Corporation ', 'LivaNova Plc ', 'Osypka AG ', 'Alivecor, Inc. '

The key factors driving this market for cardiac monitoring and cardiac rhythm management devices include increasing prevalence of cardiovascular problems, rising expenses of treating cardiac diseases, rising use of ambulatory and home services, favorable government regulation, and technical improvements. The market for cardiac monitoring and cardiac rhythm management devices is being driven by the development of cutting-edge cardiac devices including MRI pacemakers, subcutaneous ICDs, and Automated External Defibrillators (AEDs). In the United States, cardiovascular diseases (CVDs) constitute a leading cause of death. According to the WHO, CVDs are thought to be the cause of one-fourth of all fatalities.

Today's cardiac rhythm management (CRM) devices are becoming more important for more than just monitoring and managing cardiac issues. They are also helping to restore, repair, and heal. Over the past few decades, the use of CRM devices has significantly increased as a result of rising life expectancy and ongoing technological advancements that have broadened their capabilities. Leading biotech companies have also made significant contributions to the field's R&D.

North America will dominate the global cardiac monitoring and cardiac rhythm management device market during the forecast period. The most common type of heart disease, coronary artery disease, affects 382,820 people in the United States, and approximately 805,000 Americans suffer from heart attacks annually.Another important factor driving market revenue growth is the presence of key players like Medtronic, Abbott, and General Electric Company, among others.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Cardiac Monitoring and Cardiac Rhythm Management Devices Market News

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cardiac Monitoring and Cardiac Rhythm Management Devices Market?

Who are the key vendors in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market?

What is the key driver of Cardiac Monitoring and Cardiac Rhythm Management Devices Market?

What is the key market trend for Cardiac Monitoring and Cardiac Rhythm Management Devices Market?

Which region accounted for the largest share in Cardiac Monitoring and Cardiac Rhythm Management Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300